Currently holds a position at Retrophin Inc
Position | Company | Period |
---|---|---|
Director | Retrophin Inc | Jan. 4, 2019 - |
President, Chief Executive Officer, Director | Retrophin Inc | Nov. 10, 2014 - Jan. 4, 2019 |
President, Interim Chief Executive Officer, Chief Operating Officer, Director | Retrophin Inc | Sept. 30, 2014 - Nov. 10, 2014 |
President, Chief Operating Officer, Director | Retrophin Inc | May 28, 2014 - Sept. 30, 2014 |
Independent Director | Retrophin Inc | Dec. 17, 2012 - May 28, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-12-01 | 2022-11-29 |
Acer Therapeutics Inc
(ACER)
|
B Purchase |
409,836
+554.5%
1.22500,000 USD |
409,836 +554.5% | 1.22 | 500,000 USD | |
2022-05-12 | 2022-05-11 |
Retrophin Inc
(RTRX)
|
S Sale |
2,575
-1.7%
21.9256,457 USD |
2,575 -1.7% | 21.92 | 56,457 USD | |
2021-12-13 | 2021-12-10 |
Acer Therapeutics Inc
(ACER)
|
B Purchase |
7,984
+12.1%
2.0416,287 USD |
7,984 +12.1% | 2.04 | 16,287 USD | |
2021-12-13 | 2021-12-09 |
Acer Therapeutics Inc
(ACER)
|
B Purchase |
2,016
+3.2%
2.154,334 USD |
2,016 +3.2% | 2.15 | 4,334 USD | |
2021-11-18 | 2021-11-16 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
31,800
-17.5%
29.39934,602 USD |
31,800 -17.5% | 29.39 | 934,602 USD | |
2021-11-09 | 2021-11-05 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
10,000
-5.8%
26.23262,300 USD |
10,000 -5.8% | 26.23 | 262,300 USD | |
2021-11-03 | 2021-11-02 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
3,500
-15.2%
30.00105,000 USD |
3,500 -15.2% | 30.00 | 105,000 USD | |
2021-11-03 | 2021-11-01 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
5,000
-17.9%
29.48147,400 USD |
5,000 -17.9% | 29.48 | 147,400 USD | |
2021-10-08 | 2021-10-07 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
32,000
-14.4%
26.26840,320 USD |
32,000 -14.4% | 26.26 | 840,320 USD | |
2021-10-08 | 2021-10-07 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
28,000
-11.2%
26.23734,440 USD |
28,000 -11.2% | 26.23 | 734,440 USD | |
2021-04-20 | 2021-04-16 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
10,000
-5.0%
26.23262,300 USD |
10,000 -5.0% | 26.23 | 262,300 USD | |
2021-03-19 | 2021-03-17 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
7,727
-3.9%
27.56212,956 USD |
7,727 -3.9% | 27.56 | 212,956 USD | |
2021-03-19 | 2021-03-17 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
10,000
-4.8%
27.35273,500 USD |
10,000 -4.8% | 27.35 | 273,500 USD | |
2021-02-02 | 2021-02-02 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
25,000
-11.3%
30.75768,750 USD |
25,000 -11.3% | 30.75 | 768,750 USD | |
2020-12-16 | 2020-12-15 |
Retrophin Inc
(RTRX)
|
S Sale |
5,549
-2.7%
26.02144,385 USD |
5,549 -2.7% | 26.02 | 144,385 USD | |
2020-12-04 | 2020-12-02 |
Retrophin Inc
(RTRX)
|
S Sale |
7,891
-3.8%
23.43184,849 USD |
7,891 -3.8% | 23.43 | 184,849 USD | |
2020-11-06 | 2020-11-06 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
20,625
-8.8%
23.00474,375 USD |
20,625 -8.8% | 23.00 | 474,375 USD | |
2020-11-06 | 2020-11-05 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
2,500
-1.1%
21.2653,150 USD |
2,500 -1.1% | 21.26 | 53,150 USD | |
2020-08-06 | 2020-08-05 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
2,500
-1.0%
19.6849,200 USD |
2,500 -1.0% | 19.68 | 49,200 USD | |
2020-07-28 | 2020-07-24 |
Acer Therapeutics Inc
(ACER)
|
B Purchase |
45,000
+238.0%
3.50157,500 USD |
45,000 +238.0% | 3.50 | 157,500 USD | |
2020-05-14 | 2020-05-14 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
3,062
-1.2%
15.0946,206 USD |
3,062 -1.2% | 15.09 | 46,206 USD | |
2020-05-14 | 2020-05-13 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
4,063
-1.6%
16.4166,674 USD |
4,063 -1.6% | 16.41 | 66,674 USD | |
2020-05-14 | 2020-05-12 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
1,000
-0.4%
17.1617,160 USD |
1,000 -0.4% | 17.16 | 17,160 USD | |
2020-05-06 | 2020-05-05 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
2,500
-1.0%
15.8839,700 USD |
2,500 -1.0% | 15.88 | 39,700 USD | |
2020-03-09 | 2020-03-05 |
Retrophin Inc
(RTRX)
|
S Sale |
4,359
-1.7%
15.3666,939 USD |
4,359 -1.7% | 15.36 | 66,939 USD | |
2020-02-07 | 2020-02-05 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
2,500
-1.0%
16.6241,550 USD |
2,500 -1.0% | 16.62 | 41,550 USD | |
2019-07-05 | 2019-07-03 |
Acer Therapeutics Inc
(ACER)
|
B Purchase |
5,000
+36.0%
3.7218,581 USD |
5,000 +36.0% | 3.72 | 18,581 USD | |
2019-05-24 | 2019-05-22 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
B Purchase |
3,000
+150.0%
3.5710,710 USD |
3,000 +150.0% | 3.57 | 10,710 USD | |
2019-05-16 | 2019-05-15 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
1,838
-0.7%
17.8232,753 USD |
1,838 -0.7% | 17.82 | 32,753 USD | |
2019-05-16 | 2019-05-14 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
1,838
-0.7%
17.7932,698 USD |
1,838 -0.7% | 17.79 | 32,698 USD | |
2019-03-14 | 2019-03-12 |
BioCryst Pharmaceuticals Inc
(BCRX)
|
B Purchase |
2,000
+inf%
8.3016,600 USD |
2,000 +inf% | 8.30 | 16,600 USD | |
2019-02-13 | 2019-02-12 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
1,065
-0.4%
21.5022,898 USD |
1,065 -0.4% | 21.50 | 22,898 USD | |
2019-02-13 | 2019-02-11 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
1,065
-0.4%
21.3822,770 USD |
1,065 -0.4% | 21.38 | 22,770 USD | |
2018-12-21 | 2018-12-21 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
900
-0.3%
22.3520,111 USD |
900 -0.3% | 22.35 | 20,111 USD | |
2018-12-21 | 2018-12-20 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
6,188
-2.3%
21.97135,958 USD |
6,188 -2.3% | 21.97 | 135,958 USD | |
2018-11-16 | 2018-11-15 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
4,464
-1.7%
24.21108,089 USD |
4,464 -1.7% | 24.21 | 108,089 USD | |
2018-11-16 | 2018-11-14 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
600
-0.2%
24.5814,745 USD |
600 -0.2% | 24.58 | 14,745 USD | |
2018-11-16 | 2018-11-14 |
Retrophin Inc
(RTRX)
|
PS Planned sale |
4,950
-1.9%
23.63116,990 USD |
4,950 -1.9% | 23.63 | 116,990 USD | |
2017-12-18 | 2017-12-14 |
Acer Therapeutics Inc
(ACER)
|
B Purchase |
2,000
+16.8%
12.0024,000 USD |
2,000 +16.8% | 12.00 | 24,000 USD |